| Name | Sav-on Pharmacy #182 |
|---|---|
| Organization Name | Albertsons Llc |
| Location | 250 S Eagle Rd, Eagle, Idaho 83616 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (208) 939-9854 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Here are a few basic facts that Americans need to keep in mind before they go to the polls, and afterward. First, most aspects of the reform do not go into effect until 2014. Second, things are indeed bad out there: The costs of medical care and insurance premiums are (still) rising, and some employers are (still) dropping coverage. But for that, you should blame the long-standing health care crisis and the current bad economy. Health reform is supposed to help with these problems (10/23).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 5 days ago
| NPI Number | 1386690899 |
| Organization Name | ALBERTSONS LLC |
| Doing Business As | SAV-ON PHARMACY #0182 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 250 S Eagle Rd, Eagle, ID 83616 |
| Phone Number | 208-939-9854 |
News Archive
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Here are a few basic facts that Americans need to keep in mind before they go to the polls, and afterward. First, most aspects of the reform do not go into effect until 2014. Second, things are indeed bad out there: The costs of medical care and insurance premiums are (still) rising, and some employers are (still) dropping coverage. But for that, you should blame the long-standing health care crisis and the current bad economy. Health reform is supposed to help with these problems (10/23).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 5 days ago
| NPI Number | 1508307653 |
| Organization Name | ALBERTSONS LLC |
| Doing Business As | SAV-ON PHARMACY |
| Type | Pharmacy |
| Address | 250 S Eagle Rd, Eagle, ID 83616 |
| Phone Number | 208-939-9850 |
News Archive
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Here are a few basic facts that Americans need to keep in mind before they go to the polls, and afterward. First, most aspects of the reform do not go into effect until 2014. Second, things are indeed bad out there: The costs of medical care and insurance premiums are (still) rising, and some employers are (still) dropping coverage. But for that, you should blame the long-standing health care crisis and the current bad economy. Health reform is supposed to help with these problems (10/23).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 5 days ago
News Archive
Parabon NanoLabs, a leading designer and manufacturer of breakthrough products at the nanoscale, announced today its award of a National Science Foundation (NSF) Small Business Innovative Research (SBIR) grant.
Dr Karen Rosenbloom from the School of Pharmacy at the University of Hertfordshire and Ruth Goldstein from the Midlands have won first prize in the regional Health and Social Care Awards awarded by the NHS Institute for Innovation and Improvement. Their research now goes forward to the national awards final which will take place on 13 December.
Targeted therapies are currently available for about one-third of people with lung adenocarcinoma, the most common kind of lung cancer.
Here are a few basic facts that Americans need to keep in mind before they go to the polls, and afterward. First, most aspects of the reform do not go into effect until 2014. Second, things are indeed bad out there: The costs of medical care and insurance premiums are (still) rising, and some employers are (still) dropping coverage. But for that, you should blame the long-standing health care crisis and the current bad economy. Health reform is supposed to help with these problems (10/23).
Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that it has demonstrated human proof-of-concept with a microRNA therapeutic from an ongoing clinical study evaluating RG-101, a wholly-owned, GalNac-conjugated anti-miR targeting microRNA-122 ("miR-122"), for the treatment of hepatitis C virus infection ("HCV").
› Verified 5 days ago
Sav-on Pharmacy #182 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 250 S Eagle Rd, Eagle, Idaho 83616 Phone: (208) 939-9854 | |
Walgreens #12124 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 265 S Eagle Rd, Eagle, Idaho 83616 Phone: (208) 319-0543 |